160 related articles for article (PubMed ID: 21838483)
1. Combined liver-kidney transplantation in familial amyloidotic polyneuropathy TTR V30M: nephrological assessment.
Lobato L; Beirão I; Seca R; Pessegueiro H; Rocha MJ; Queiroz J; Gomes M; Henriques AC; Teixeira M; Almeida R
Amyloid; 2011 Jun; 18 Suppl 1():190-2. PubMed ID: 21838483
[No Abstract] [Full Text] [Related]
2. Ten years of international experience with liver transplantation for familial amyloidotic polyneuropathy: results from the Familial Amyloidotic Polyneuropathy World Transplant Registry.
Herlenius G; Wilczek HE; Larsson M; Ericzon BG;
Transplantation; 2004 Jan; 77(1):64-71. PubMed ID: 14724437
[TBL] [Abstract][Full Text] [Related]
3. Modeling familial amyloidotic polyneuropathy (Transthyretin V30M) in Drosophila melanogaster.
Berg I; Thor S; Hammarström P
Neurodegener Dis; 2009; 6(3):127-38. PubMed ID: 19372706
[TBL] [Abstract][Full Text] [Related]
4. Impact of liver transplantation on the natural history of oculopathy in Portuguese patients with transthyretin (V30M) amyloidosis.
Beirão JM; Malheiro J; Lemos C; Matos E; Beirão I; Pinho-Costa P; Torres P
Amyloid; 2015 Mar; 22(1):31-5. PubMed ID: 25475560
[TBL] [Abstract][Full Text] [Related]
5. Familial amyloid polyneuropathy and liver transplantation.
Monteiro E; Freire A; Barroso E
J Hepatol; 2004 Aug; 41(2):188-94. PubMed ID: 15288465
[No Abstract] [Full Text] [Related]
6. Transthyretin-related familial amyloidotic polyneuropathy.
Ando Y; Nakamura M; Araki S
Arch Neurol; 2005 Jul; 62(7):1057-62. PubMed ID: 16009758
[TBL] [Abstract][Full Text] [Related]
7. [Gene therapy in familial amyloidotic polyneuropathy by single-stranded oligonucleotides (SSOs)].
Nakamura M; Ando Y
Rinsho Byori; 2004 Oct; 52(10):804-12. PubMed ID: 15624495
[TBL] [Abstract][Full Text] [Related]
8. Model for end-stage liver disease (MELD) exception for familial amyloidotic polyneuropathy.
Pomfret E; Gish RG; Brandhagen D
Liver Transpl; 2006 Dec; 12(12 Suppl 3):S100-1. PubMed ID: 17123281
[No Abstract] [Full Text] [Related]
9. A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation.
Ando Y; Terazaki H; Nakamura M; Ando E; Haraoka K; Yamashita T; Ueda M; Okabe H; Sasaki Y; Tanihara H; Uchino M; Inomata Y
Transplantation; 2004 Feb; 77(3):345-9. PubMed ID: 14966406
[TBL] [Abstract][Full Text] [Related]
10. Report from the Familial Amyloidotic Polyneuropathy World Transplant Registry (FAPWTR) and the Domino Liver Transplant Registry (DLTR).
Ericzon BG; Larsson M; Herlenius G; Wilczek HE;
Amyloid; 2003 Aug; 10 Suppl 1():67-76. PubMed ID: 14640044
[TBL] [Abstract][Full Text] [Related]
11. Severe congestive heart failure with cardiac liver cirrhosis 10 years after orthotopic liver transplantation for familial amyloidotic polyneuropathy.
Sakashita N; Ando Y; Haraoka K; Terazaki H; Yamashita T; Nakamura M; Takeya M
Pathol Int; 2006 Jul; 56(7):408-12. PubMed ID: 16792551
[TBL] [Abstract][Full Text] [Related]
12. The inflammatory response to sciatic nerve injury in a familial amyloidotic polyneuropathy mouse model.
Gonçalves NP; Teixeira-Coelho M; Saraiva MJ
Exp Neurol; 2014 Jul; 257():76-87. PubMed ID: 24800914
[TBL] [Abstract][Full Text] [Related]
13. TTR-familial amyloid polyneuropathy--neurological aspects.
Said G; Planté-Bordeneuve V
Amyloid; 2012 Jun; 19 Suppl 1():25-7. PubMed ID: 22620963
[TBL] [Abstract][Full Text] [Related]
14. Spatial visual contrast sensitivity in liver transplanted Portuguese familial amyloidotic polyneuropathy (ATTR V30M) patients.
Beirão M; Matos E; Reis R; Beirão I; Costa PP; Torres P
Amyloid; 2012 Sep; 19(3):152-5. PubMed ID: 22856676
[TBL] [Abstract][Full Text] [Related]
15. [Familial amyloid polyneuropathy: liver transplantation as first-line therapy].
Yamashita T
Brain Nerve; 2014 Jul; 66(7):763-71. PubMed ID: 24998821
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome of patients with hereditary transthyretin V30M amyloidosis with polyneuropathy after liver transplantation.
Okumura K; Yamashita T; Masuda T; Misumi Y; Ueda A; Ueda M; Obayashi K; Jono H; Yamashita S; Inomata Y; Ando Y
Amyloid; 2016; 23(1):39-45. PubMed ID: 26763274
[TBL] [Abstract][Full Text] [Related]
17. Amyloid turnover after liver transplantation in FAP.
Obayashi K; Ueda M; Jono H; Yamashita T; Yazaki M; Kametani F; Ohya Y; Inomata Y; Ikeda S; Ando Y
Amyloid; 2011 Jun; 18 Suppl 1():187-9. PubMed ID: 21838482
[No Abstract] [Full Text] [Related]
18. A transgenic rat with the human ATTR V30M: a novel tool for analyses of ATTR metabolisms.
Ueda M; Ando Y; Hakamata Y; Nakamura M; Yamashita T; Obayashi K; Himeno S; Inoue S; Sato Y; Kaneko T; Takamune N; Misumi S; Shoji S; Uchino M; Kobayashi E
Biochem Biophys Res Commun; 2007 Jan; 352(2):299-304. PubMed ID: 17126291
[TBL] [Abstract][Full Text] [Related]
19. Domino liver transplantation: risks and benefits.
Ericzon BG; Larsson M; Wilczek HE
Transplant Proc; 2008 May; 40(4):1130-1. PubMed ID: 18555132
[TBL] [Abstract][Full Text] [Related]
20. Impact of liver transplantation on familial amyloidotic polyneuropathy (FAP) patients' symptoms and complications.
Suhr OB
Amyloid; 2003 Aug; 10 Suppl 1():77-83. PubMed ID: 14640045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
